Zurich Cantonal Bank
KURA icon

Zurich Cantonal Bank’s Kura Oncology KURA Stock Holding History

Zurich Cantonal Bank’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$627K Buy
57,143
+10,780
+23% +$102K ﹤0.01% 1820
2026
Q1 		$377K Hold
46,363
– – ﹤0.01% 1970
2025
Q4 		$482K Buy
46,363
+13,579
+41% +$142K ﹤0.01% 1809
2025
Q3 		$290K Hold
32,784
– – ﹤0.01% 2016
2025
Q2 		$189K Hold
32,784
– – ﹤0.01% 2162
2025
Q1 		$216K Buy
32,784
+6,154
+23% +$48K ﹤0.01% 2063
2024
Q4 		$232K Buy
26,630
+8,570
+47% +$123K ﹤0.01% 2085
2024
Q3 		$353K Hold
18,060
– – ﹤0.01% 1773
2024
Q2 		$372K Buy
18,060
+4,654
+35% +$95.7K ﹤0.01% 1693
2024
Q1 		$286K Sell
13,406
-2,987
-18% -$58.1K ﹤0.01% 1839
2023
Q4 		$236K Buy
16,393
+6,797
+71% +$66.8K ﹤0.01% 1993
2023
Q3 		$87.5K Hold
9,596
– – ﹤0.01% 2416
2023
Q2 		$102K Hold
9,596
– – ﹤0.01% 2347
2023
Q1 		$117K Hold
9,596
– – ﹤0.01% 2202
2022
Q4 		$119K Buy
9,596
+2,650
+38% +$38.5K ﹤0.01% 2167
2022
Q3 		$95K Hold
6,946
– – ﹤0.01% 2260
2022
Q2 		$127K Hold
6,946
– – ﹤0.01% 2079
2022
Q1 		$112K Hold
6,946
– – ﹤0.01% 2243
2021
Q4 		$97K Hold
6,946
– – ﹤0.01% 2524
2021
Q3 		$130K Hold
6,946
– – ﹤0.01% 2183
2021
Q2 		$145K Hold
6,946
– – ﹤0.01% 2024
2021
Q1 		$196K Hold
6,946
– – ﹤0.01% 1786
2020
Q4 		$227K Sell
6,946
-179
-3% -$6.29K ﹤0.01% 1764
2020
Q3 		$218K Hold
7,125
– – ﹤0.01% 1532
2020
Q2 		$116K Buy
7,125
+3,292
+86% +$47.5K ﹤0.01% 1866
2020
Q1 		$38K Hold
3,833
– – ﹤0.01% 2068
2019
Q4 		$53K Hold
3,833
– – ﹤0.01% 2110
2019
Q3 		$58K Buy
3,833
+1,009
+36% +$18K ﹤0.01% 1935
2019
Q2 		$56K Buy
2,824
+2,420
+599% +$40.2K ﹤0.01% 1984
2019
Q1 		$7K Sell
404
-960
-70% -$14.8K ﹤0.01% 2538
2018
Q4 		$19K Buy
+1,364
New +$18.1K ﹤0.01% 2463

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Zurich Cantonal Bank's KURA Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Kura Oncology (KURA) stake by 23% in Q2 2026, buying an estimated $102K and bringing the position to 57,143 shares worth $627K. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

Zurich Cantonal Bank first reported a position in KURA in Q4 2018 and has held it in 31 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Zurich Cantonal Bank held 57,143 shares of Kura Oncology worth $627K as of Q2 2026.
  • Zurich Cantonal Bank bought 10,780 Kura Oncology shares in Q2 2026, an estimated $102K.
  • Kura Oncology made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1820 holding.
  • Zurich Cantonal Bank first reported a position in Kura Oncology in Q4 2018 and has held it in 31 quarters since.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.